Drugmaker Merck & Co. said Thursday it lost $531 million in the fourth quarter due to nearly $4 billion charges, including writeoffs and restructuring costs from its acquisition of Schering-Plough Corp. in 2009.
Drugmaker Merck & Co. said Thursday it doesn't expect arbitrators to rule until sometime next year on its multi-billion-dollar dispute with Johnson & Johnson over rights to two lucrative drugs for immune disorders.
Drugmaker Merck & Co. plans to appeal a federal court verdict that a former subsidiary caused the commonwealth of Massachusetts to overpay pharmacists for a widely used asthma medication, the company said Thursday.
Drugmaker Merck & Co. said Tuesday that arbitration will begin in late September in its dispute with Johnson & Johnson over revenue from two blockbuster drugs for rheumatoid arthritis and other immune disorders.
